The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.
about
Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancerChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesSchwann cells induce cancer cell dispersion and invasion.Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancerMicroenvironmental regulation of metastasisEmergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinomaIdentification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.The role of chemoattractant receptors in shaping the tumor microenvironment.Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatmentTargeting chemokine pathways in esophageal adenocarcinoma.Stromal SLIT2 impacts on pancreatic cancer-associated neural remodelingAssociation of diabetes and perineural invasion in pancreatic cancer.Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradientThe metastasis-promoting roles of tumor-associated immune cellsEarly expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesisNeural invasion in pancreatic cancer: the past, present and future.Continuous Low-dose-rate Irradiation of Iodine-125 Seeds Inhibiting Perineural Invasion in Pancreatic Cancer.The good and the bad of chemokines/chemokine receptors in melanoma.Midkine promotes perineural invasion in human pancreatic cancer.Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.Chemokines and chemokine receptors: new insights into cancer-related inflammation.Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.Molecular pathways and targets in cancer-related inflammation.The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.Perineural invasion and associated pain in pancreatic cancer.CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function.The immune network in pancreatic cancer development and progression.Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells.Preliminary study correlating CX3CL1/CX3CR1 expression with gastric carcinoma and gastric carcinoma perineural invasion.Role of CX3CL1 in Diseases.Mechanisms of Perineural Invasion.Implications of chemokine receptors and inflammatory lipids in cancer.Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma.How Schwann cells facilitate cancer progression in nerves.
P2860
Q24621214-55A1C4AC-A81C-49A3-95EE-EA5C7D6423C2Q26866236-2B807A21-04CA-46F4-AC4A-564B2EC1E3EBQ27331510-0EF6681A-C4AE-46D6-BFDC-3E00DFD6A351Q28473944-71154BE1-1950-4076-889B-DAB821A23FADQ29547660-3EE6EB7F-FB1E-4DAB-A5D8-A13C71F2E288Q33728994-FF323133-3E6D-4174-91EE-4E957C37FA1EQ33959320-95B70CD5-FD1D-447D-8B99-E3AE305EBFF1Q33993124-7E2BA7C8-B77C-4C20-B100-01BE8FD36B98Q34405141-B747C138-1CF3-43E9-9623-B2724D76D718Q35683268-95D4B772-3063-47A9-8B32-7B063A9AE357Q35739397-D94417B6-60F4-473C-B269-8331F71932AEQ35741542-A827682A-CD71-4FC0-80B0-136481AEC41AQ36150219-E315E76A-394C-40D6-9F5F-8F6C6FBA88FDQ36187424-87F215F6-558B-4FB8-9355-718DE5063BA1Q36347116-54184317-4442-463F-8F2E-0EC9134E2D07Q36530749-4241E7B7-E732-4D9E-81FD-00155B093F58Q36811526-594BF60F-B017-4EFB-9BD3-FF440736384CQ36972016-E8DE6A81-CB67-4B86-8000-08129A45BE83Q37279237-8B63F3C6-5F1A-4AD4-8D2C-614D296CE059Q37334253-6D923297-5C6C-4D4C-B54D-425566BDC600Q37353612-C0C1882F-94A9-46D9-BA81-E62166309DC4Q37394981-FCA0B3E0-D02F-42CE-B835-03CBE226F046Q37649996-64A17C92-CC3F-4394-8740-A0C21AD6C6ADQ37670253-0CE291EF-1650-437B-9640-7F6056BB0C3AQ37694068-A4858EB5-383B-46A1-AF81-4D6E63DFD50FQ37700771-70D5A09C-9744-475C-A26B-54AD83B25DB0Q37729131-61A11E72-85AA-437B-91D7-7443C1B03908Q37739999-0B4B0607-2671-49CE-9BC5-82F67954E136Q37937421-85FADC50-4B0B-4C9B-8C2C-8FDDF32F39C6Q37998010-2A12760D-A83D-45AE-9E72-17D908941EDEQ38121412-D90DE73A-4E4A-4E05-B3C7-4089BFFE87F1Q38223355-25F59814-CE0D-47C2-89FD-F09D844AF02EQ38633024-2CAA9C94-4543-46F0-8A94-4D4578E1E4D4Q38803357-A457A01E-E893-45CE-814A-64F05AF34E57Q38813214-A6639DB2-7608-4E8A-B169-059BA3B203A6Q38819710-65A2E988-E40E-4988-A49D-21C70CF4AAB3Q38912259-04B15C9C-5539-4C01-9D24-B5BCB852F71CQ39085104-67A402F9-4DFE-436A-A8BA-F311E44D9FB2Q39125415-EFAA3297-5E87-49D0-8DEE-AA364310336DQ39384853-25F9EBBA-8084-4B70-BFDE-A1AF9E0B26F3
P2860
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@en
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@nl
type
label
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@en
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@nl
prefLabel
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@en
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@nl
P2093
P50
P1433
P1476
The chemokine receptor CX3CR1 ...... creatic ductal adenocarcinoma.
@en
P2093
Alberto Malesci
Alessandro Zerbi
Annarita Destro
Giuseppe Fedele
Luigi Cervo
Michele Reni
Paola Allavena
Valerio Di Carlo
P304
P356
10.1158/0008-5472.CAN-08-1810
P407
P50
P577
2008-11-01T00:00:00Z